Archives of Disease in Childhood · 2008 · 36 citations · 4 references
MedicineMaternal HealthPharmacologyChild DevelopmentSubstance Use DisordersVisual DevelopmentDevelopmental PharmacologyPediatric Visual ElectrophysiologyPrenatal DevelopmentPrenatal ToxicityVisual Evoked PotentialsNeurodevelopmental Outcomes After Prenatal ExposurePerinatal Drug ExposurePrenatal Drug ExposurePrenatal Substance ExposureSubstance Exposure At Birth
We investigated the effects of maternal drug misuse on neonatal visual evoked potentials (VEPs). Flash VEPs were recorded within 4 days of birth from 21 term infants of mothers misusing drugs and prescribed substitute methadone and 20 controls. Waveforms were classified as typical, atypical, immature or non-detectable, and amplitude and latencies were measured. VEPs from drug-exposed infants were less likely to be of typical waveform and more likely to be immature or non-detectable (p<0.01) than those of control infants. They were also smaller in amplitude (median 10.8 vs 24.4 microV, p<0.001). VEPs of drug-exposed infants had matured after 1 week but remained of lower amplitude than VEPs of newborn controls (p<0.01) and were non-detectable in 15%. Flash VEPs differ between maternal drug-exposed and non-drug-exposed newborns. Future research should address the specific effects of maternal methadone and/or other illicit drug misuse on infant VEPs, and associations between neonatal VEPs and subsequent visual development.
4
Nystagmus secondary to drug exposure in utero
Alan Mulvihill, Peter Cackett, Nick George et al. · British Journal of Ophthalmology · 2006 · 44 citations
Medicine, Neurology, Pediatrics +13